The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Pyridostigmine bromide
Pyridostigmine bromide · PYRIDOSTIGMINE BROMIDE 105 mg/1 · Tablet, Extended Release · Oral · Amneal Pharmaceuticals LLC
NDC 60846-0559-10 · 10 CARTON in 1 BAG / 1 BLISTER PACK in 1 CARTON / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for pyridostigmine bromide (oral solid) in the next 90 days
sole-source market · price up 3% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Amneal Complex Products Research LLCUnited Statesanalysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA217604
- TE code
- —
- Approval date
- Oct 4, 2024
- Patents / exclusivity
- 9 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11478425 | Jun 18, 2038 |
| patent | 12042559 | Jun 18, 2038 |
| patent | 10925833 | Jun 18, 2038 |
| patent | 12233166 | Jun 18, 2038 |
| patent | 10987311 | Jun 18, 2038 |
| patent | 10881617 | Jun 18, 2038 |
| patent | 11666536 | Jun 18, 2038 |
| patent | 11911515 | Jun 18, 2038 |
| patent | 11229606 | Jun 18, 2038 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Pyridostigmine bromide (Tablet, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Alvogen, Inc. | PYRIDOSTIGMINE BROMIDE 180 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals LLC | PYRIDOSTIGMINE BROMIDE 105 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bausch Health US, LLC | PYRIDOSTIGMINE BROMIDE 180 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Oceanside Pharmaceuticals | PYRIDOSTIGMINE BROMIDE 180 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Pyridostigmine bromide — NDC 60846-0559-10," retrieved September 3, 2026, https://drugdashboards.com/drug/60846055910.
Free to cite with attribution — see how the data is put together.